Skip to contentC
Cumberland Pharmaceuticals Inc
C
CPIXCumberland Pharmaceuticals Inc Q1 2021 · 10-Q
Revenue$10.54M$10.54Mno prior Q1 2020 on file Net Income$166.83K$166.83Kno prior Q1 2020 on file EPS Diluted$0.01$0.01no prior Q1 2020 on file Operating Income-$324,300— Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
Free Cash Flowderived$1,766,091— Margins · derivedOperating margin-3.1%
Net margin1.6%
ended Mar 31, 2021 · filed May 14, 2021 · 44 d after period end